Trial Details

Not Recruiting
Basic Information
Clinical ID c3068
Identifier EUCTR2013-000891-13-DE
Trial Title A randomised, double-blind, placebo-controlled multi-centre study to investigate the effectiveness and safety of STW5-II as add-on treatment for induction of remission in patients with mild to moderate ulcerative colitits
Trial URL Visit Original Page
Study Information
Study Results

No results available

Conditions Ulcerative colitis;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]
Interventions Trade Name: Iberogast N Product Name: Iberogast N Product Code: STW5-II Pharmaceutical Form: Oral drops, liquid INN or Proposed INN: Bitterschleifenblume-ganzpflanze 1,5ml/10ml Other descriptive name: BITTER CANDYTUFT FRESH PLANT EXTRACT Concentration unit: ml millilitre(s) Concentration type: equal Concentration number: 15- INN or Proposed INN: Kmel 2ml/10ml Other descriptive name: CARVI EXTRACTUM FLUIDUM Concentration unit: ml millilitre(s) Concentration type: equal Concentration number: 20- INN or Proposed INN: Pfefferminzbter 1ml/10ml Other descriptive name: MENTHA PIPERITA L. FOLIUM Concentration unit: ml millilitre(s) Concentration type: equal Concentration number: 10- INN or Proposed INN: Sholzwurzel 1ml/10ml Other descriptive name: GLYCYRRHIZA GLABRA ROOT Concentration unit: ml millilitre(s) Concentration type: equal Concentration number: 10- INN or Proposed INN: Kamillenblen 3ml/10ml Other descriptive name: MATRICARIA RECUTITA L. FLOS Concentration unit: ml millilitre(s) Concentration type: equal Concentration number: 30- INN or Proposed INN: Melissenblter 15ml/10ml Other descriptive name: MELISSAE FOLII DRY AQUEOUS EXTRACT Concentration unit: ml millilitre(s) Concentration type: equal Concentration number: 15- Pharmaceutical form of the placebo: Oral drops, liquid Route of administration of the placebo: Oral use
Participant Information
Sponsor Steigerwald Arzneimittelwerk GmbH
City -
Country/Region Germany
Enrollment Criteria
Sex Requirement NOT SPECIFIED
Age Requirement -
Study Design
Study Type Interventional clinical trial of medicinal product
Phase Not Available
Time Information
Start Date 2025-04-24
Primary Completion Date -
Completion Date -